Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observational study of patients with infective endocarditis

Official title: Prospective Cohort Study of Patients With Infective Endocarditis Admitted at Cardiology Institute of Pitié-Salpêtrière Hospital

Run by Assistance Publique - Hôpitaux de Paris · NCT04992923 · Data updated 2026-11-12

This study is collecting health information from patients with infective endocarditis to see how to better treat and manage the condition over time.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment700 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedSeptember 15, 2020
Main results expectedSeptember 2040
Study endsMarch 2041
Registry record updatedNovember 21, 2025
Trial IDNCT04992923 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with a confirmed diagnosis of infective endocarditis according to European Society of Cardiology criteria.

Probably not a fit

Patients who oppose participation in the study will not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to gather comprehensive clinical data from patients diagnosed with infective endocarditis (IE) at the Pitié-Salpêtrière Hospital. It will involve collecting demographic, clinical, laboratory, and imaging data at the time of diagnosis and during follow-up, which can extend up to 10 years. The goal is to improve the management and prognosis of IE by establishing a large prospective cohort, as current guidelines are primarily based on expert consensus rather than robust data.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies and better prognostic outcomes for patients with infective endocarditis.

How similar studies have gone: While there is limited prospective data on infective endocarditis, this approach aims to fill a significant gap in the existing literature, suggesting it is a novel and necessary endeavor.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with confirmed IE according to European Society of Cardiology criteria

Exclusion Criteria:

* Opposition of the patient to participate

Where it's running

  • APHP Pitié-Salpêtrière Hospital, Department of Cardiology
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Nadjib Hammoudi, MD, PhD — Pitié-Salpêtrière Hospital
  • Study coordinator: Nadjib Hammoudi, MD, PhD
  • Email: nadjib.hammoudi@aphp.fr
  • Phone: +33 142165535

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.